ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer

Title
ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer
Authors
Keywords
ANLN, Prognostic biomarker, Breast cancer, Proliferation, Antibody-based proteomics
Journal
BMC CANCER
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-11-18
DOI
10.1186/s12885-016-2923-8

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now